Adtalem Global Education is Tuesday's IBD Stock Of The Day as the leading provider of health care education, which has bet on ...

GeneDx is Monday's IBD Stock Of The Day. Shares of the DNA-reading player are eyeing multiple buy points on a massive gain.

Nvidia is IBD Stock Of The Day as the AI chipmaker rises above its 50-day moving average and a downward-sloping trendline.

GE Vernova bounced off its 50-day line, offering a buying opportunity. Thursday's IBD Stock Of The Day is already up 130% ...

Teva Pharmaceutical (NYSE: TEVA) and Sanofi (NASDAQ: SNY) stocks were rising on Tuesday after the companies announced successful results of a phase 2 study involving the treatment of patients with ...

Sanofi stock rose nearly 7% ... Both UC and CD indications are primary forms of IBD, marked by chronic inflammation in the gastrointestinal tract. In recent years, there has been a surge in ...

In a report released today, Sam Slutsky from LifeSci Capital maintained a Buy rating on Spyre Therapeutics (SYRE – Research Report), with a ...

The duo has planned a Phase 3 program for the drug in IBD, subject to regulatory feedback. “The results from the RELIEVE UCCD study have exceeded our expectations, and I am deeply moved by the ...

Piper Sandler analyst Christopher Raymond raised the firm’s price target on AbbVie (ABBV) to $220 from $212 and keeps an Overweight rating on ...